Table 1 Rapid diagnostic tests reported in DHIS2, whose availability was assessed in the 2018 KHFA survey
RDT Test | Health outcome | Common | Level of reporting | WHO EDL classification |
|---|---|---|---|---|
HIV | HIV | Y | Level 2–6 | Sexually transmitted infections |
Venereal disease research laboratory (VDRL) | Syphilis | Y | Level 2–6 | Sexually transmitted infections |
Blood grouping | Blood Transfusion | Y | Level 2–6 | Haematology |
HB estimation | Anaemia | Y | Level 2–6 | Haematology |
Blood Sugar | Diabetes | Y | Level 2–6 | Clinical chemistry |
HCG (Human chorionic gonadotropin) | Pregnancy | Y | Level 2–6 | Clinical chemistry |
Urine Chemistry | UTI, Kidney Disease | Y | Level 2–6 | Clinical chemistry |
Cryptococcal Antigen (CRAG) test* | Cryptococcal Meningitis | Y | Level 2–6 | Clinical chemistry |
Malaria RDT | Malaria | Y | Level 2–3 | Bacteriology, mycology and parasitology |
Treponema Pallidum Hemagglutination (TPHA) | Syphilis | N | Level 4–6 | Sexually transmitted infections |